Finance
Drugmaker Parabilis Raises $745 Million in US IPO, Placement
Image via Bloomberg
Article Summary
44 words
Parabilis Medicines Inc., a clinical-stage cancer drug developer, raised nearly $745 million in an upsized US initial public offering that priced above its marketed range, and a private placement. This story was reported by Bloomberg. For more Finance news in Kenya, stay tuned to Masaa.
Continue Reading
Full story on Bloomberg
🔗 Clicking will take you to www.bloomberg.com



